Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death.
作者信息
Duong ThuyVy, Austin Thomas R, Brody Jennifer A, Shojaie Ali, Battle Alexis, Bader Joel S, Hong Yun Soo, Ballantyne Christie M, Coresh Josef, Gerszten Robert E, Tracy Russell P, Psaty Bruce M, Sotoodehnia Nona, Arking Dan E
机构信息
McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (T.D., Y.S.H., D.E.A.).
Cardiovascular Health Research Unit, Department of Medicine (T.R.A., J.A.B., B.M.P., N.S.), University of Washington, Seattle.
出版信息
Circ Genom Precis Med. 2024 Oct;17(5):e004494. doi: 10.1161/CIRCGEN.123.004494. Epub 2024 Sep 5.
Abstract
摘要
相似文献
1
Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death.循环血浆分析揭示蛋白质组学特征以及SVEP1在心脏性猝死中的因果作用。
Circ Genom Precis Med. 2024 Oct;17(5):e004494. doi: 10.1161/CIRCGEN.123.004494. Epub 2024 Sep 5.
2
Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker.通过质谱对剥脱性青光眼进行全面蛋白质组分析揭示SVEP1作为潜在生物标志物
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):19. doi: 10.1167/iovs.66.3.19.
3
Deep plasma and tissue proteome profiling of knockout mice reveals pathways associated with deficiency.基因敲除小鼠的深度血浆和组织蛋白质组分析揭示了与缺陷相关的途径。
J Mol Cell Cardiol Plus. 2025 Jan 10;11:100283. doi: 10.1016/j.jmccpl.2025.100283. eCollection 2025 Mar.
4
The emerging Janus face of SVEP1 in development and disease.SVEP1 在发育和疾病中的新兴双面性。
Trends Mol Med. 2023 Nov;29(11):939-950. doi: 10.1016/j.molmed.2023.08.002. Epub 2023 Sep 4.
5
Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy.在一个因LMNA基因突变导致扩张型心肌病的家族中，通过蛋白质组学鉴定用于早期检测心源性猝死的潜在生物标志物。
J Proteomics. 2016 Oct 4;148:75-84. doi: 10.1016/j.jprot.2016.07.020. Epub 2016 Jul 22.
6
Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy.获得性心肌肥厚致心源性猝死的蛋白质组学分析。
Int J Legal Med. 2023 Sep;137(5):1453-1461. doi: 10.1007/s00414-023-03038-6. Epub 2023 Jun 7.
7
Identification of TRAF2, CAMK2G, and TIMM17A as biomarkers distinguishing mechanical asphyxia from sudden cardiac death base on 4D-DIA Proteomics: A pilot study.基于4D-DIA蛋白质组学鉴定TRAF2、CAMK2G和TIMM17A作为区分机械性窒息与心源性猝死的生物标志物：一项初步研究。
J Pharm Biomed Anal. 2025 Jun 15;258:116730. doi: 10.1016/j.jpba.2025.116730. Epub 2025 Feb 3.
8
The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study.代谢综合征与心源性猝死风险：社区动脉粥样硬化风险研究。
J Am Heart Assoc. 2017 Aug 23;6(8):e006103. doi: 10.1161/JAHA.117.006103.
9
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP.血浆SVEP1水平在肥厚型心肌病中预测心血管事件的能力超越了包括NT-proBNP在内的传统临床风险模型。
Circ Heart Fail. 2025 Feb;18(2):e012343. doi: 10.1161/CIRCHEARTFAILURE.124.012343. Epub 2025 Jan 20.
10
Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.蛋白质组学分析揭示了肥厚型心肌病的一种独特的高风险分子亚型。
Heart. 2022 Oct 28;108(22):1807-1814. doi: 10.1136/heartjnl-2021-320729.
本文引用的文献
1
The emerging Janus face of SVEP1 in development and disease.SVEP1 在发育和疾病中的新兴双面性。
Trends Mol Med. 2023 Nov;29(11):939-950. doi: 10.1016/j.molmed.2023.08.002. Epub 2023 Sep 4.
2
Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing.心血管健康研究（CHS）中的蛋白质组学和群体生物学：一项具有指导访问和主动数据共享的研究设计。
Eur J Epidemiol. 2022 Jul;37(7):755-765. doi: 10.1007/s10654-022-00888-z. Epub 2022 Jul 5.
3
Coding and regulatory variants are associated with serum protein levels and disease.编码和调控变异与血清蛋白水平和疾病相关。
Nat Commun. 2022 Jan 25;13(1):481. doi: 10.1038/s41467-022-28081-6.
4
Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).蛋白质组学与老年人心房颤动风险（来自动脉粥样硬化风险社区研究 [ARIC]）。
Am J Cardiol. 2021 Dec 15;161:42-50. doi: 10.1016/j.amjcard.2021.08.064.
5
Mapping the proteo-genomic convergence of human diseases.绘制人类疾病的蛋白质基因组趋同图谱。
Science. 2021 Nov 12;374(6569):eabj1541. doi: 10.1126/science.abj1541.
6
The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8.ARIC（社区动脉粥样硬化风险研究）：JACC 重点研讨会 3/8。
J Am Coll Cardiol. 2021 Jun 15;77(23):2939-2959. doi: 10.1016/j.jacc.2021.04.035.
7
SVEP1 is a human coronary artery disease locus that promotes atherosclerosis.SVEP1 是一个人类冠状动脉疾病基因座，可促进动脉粥样硬化。
Sci Transl Med. 2021 Mar 24;13(586). doi: 10.1126/scitranslmed.abe0357.
8
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.美国国立卫生研究院生物医学高级研究与发展局（NHLBI）TOPMed 项目中对 53831 个不同基因组进行测序。
Nature. 2021 Feb;590(7845):290-299. doi: 10.1038/s41586-021-03205-y. Epub 2021 Feb 10.
9
gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler.gprofiler2——一个用于基因列表功能富集分析的 R 包和基因本体论（GO）注释工具集 g: Profiler。
F1000Res. 2020 Jul 15;9. doi: 10.12688/f1000research.24956.2. eCollection 2020.
10
Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay.使用多重修饰适体分析法测定蛋白质分析物的重现性和变异性。
J Appl Lab Med. 2019 Jul;4(1):30-39. doi: 10.1373/jalm.2018.027086. Epub 2019 Jan 22.
Zotero 插件